Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Current evidence regarding the impact of GLP-1 receptor agonists on ophthalmic diseases remains inconsistent. Retinopathy remains the dominant concern Much of the ophthalmic attention surrounding GLP-1 therapies traces back to DR
A 2024 clinical study found it produced 12% improvement in fine lines and 19% in hyperpigmentation applied three nights per week for eight weeks with no sensitization
Much like managing insulin therapy from a distance, success depends on structured follow-up, clear communication, and proactive risk management
Pick a day when you can take it easy if needed
It may almost look unreal, but for some, there may be no difference at all
For people with diabetes who are choosing between medication classes, UTI risk is one factor among many
